The EU Commission clears, subject to divestiture, a merger in the pharmaceutical industry (Hoffmann-La Roche / Boehringer Mannheim)

"Mergers Recent important decisions" In September 1997, the Swiss pharmaceutical company Hoffmann-La Roche proposed to acquire Corage Ltd., ultimate parent company of the Boehringer Mannheim Group (BM). After a preliminary appreciation of the case the Commission concluded that in clinical chemistry (‘CC’) in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • European Commission - DG TRADE (Brussels)
  • DG COMP (Brussels)

Quotation

Geraldine Emberger, John Kemp, The EU Commission clears, subject to divestiture, a merger in the pharmaceutical industry (Hoffmann-La Roche / Boehringer Mannheim), 4 February 1998, e-Competitions February 1998, Art. N° 39443

Visites 295

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues